8364 Federal Register / Vol. 86, No. 23 / Friday, February 5, 2021 / Notices 

270,544; Total Annual Hours: 67,637. 

(For policy questions regarding this 

collection contact Katherine E. Hosna at 

410–786–4993.) 

Dated: February 2, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–02441 Filed 2–4–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: Public 

Comment Request Information 

Collection Request Title: Federal Tort 

Claims Act Program Deeming 

Applications for Health Centers, OMB 

No. 0906–0035 Extension 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement for opportunity for public 

comment on proposed data collection 

projects of the Paperwork Reduction Act 

of 1995, HRSA announces plans to 

submit an Information Collection 

Request (ICR), described below, to the 

Office of Management and Budget 

(OMB). Prior to submitting the ICR to 

OMB, HRSA seeks comments from the 

public regarding the burden estimate, 

below, or any other aspect of the ICR. 

DATES: Comments on this Information 

Collection Request must be received no 

later than April 6, 2021. 

ADDRESSES: Submit your comments to 

paperwork@hrsa.gov or mail the HRSA 

Information Collection Clearance 

Officer, Room 14N136B, 5600 Fishers 

Lane, Rockville, MD 20857. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and draft 

instruments, email paperwork@hrsa.gov 

or call Lisa Wright-Solomon, the HRSA 

Information Collection Clearance Officer 

at (301) 443–1984. 

SUPPLEMENTARY INFORMATION: When 

submitting comments or requesting 

information, please include the 

information request collection title for 

reference. 

Information Collection Request Title: 

Federal Tort Claims Act Program 

Deeming Applications for Health 

Centers, OMB No. 0906–0035— 

Extension. 

Abstract: Section 224(g)–(n) of the 

Public Health Service (PHS) Act (42 

U.S.C. 233(g)–(n)), as amended, 

authorizes the ‘‘deeming’’ of entities 

receiving funds under section 330 of the 

PHS Act as PHS employees for the 

purpose of receiving Federal Tort 

Claims Act (FTCA) coverage for the 

performance of medical, surgical, 

dental, and related functions for their 

officers, board members, employees, 

and certain contractors. The Health 

Center Program is administered by 

HRSA’s Bureau of Primary Health Care. 

Health centers submit deeming 

applications annually to HRSA in the 

prescribed form and manner in order to 

obtain deemed PHS employee status, 

with the associated FTCA coverage. 

Deemed PHS employment provides 

the covered individual with immunity 

from lawsuits and related civil actions 

resulting from the performance of 

medical, surgical, dental, and related 

functions within the scope of deemed 

employment. 

The FTCA Program utilizes a web 

based application system, the Electronic 

Handbooks. The application includes 

the following: Contact information; 

Section 1: Review of Risk Management 

Systems; Section 2: Quality 

Improvement/Quality Assurance 

Attestations; Section 3: Credentialing 

and Privileging; Section 4: Claims 

Management; and Section 5: Additional 

Information, Certification, and 

Signatures. 

HRSA is proposing no changes to the 

Application for Health Center Program 

Deemed Public Health Service 

Employment Status information 

collection request to be used for health 

center deeming applications for 

Calendar Year 2022 and thereafter. 

Need and Proposed Use of the 

Information: Deeming applications must 

address certain specified criteria 

required by law in order for deeming 

determinations to be issued, and FTCA 

application forms are critical to HRSA’s 

deeming determination process. The 

application submissions provide HRSA 

with the information essential for 

application evaluation and a deeming 

determination for the purposes of FTCA 

coverage. The application information is 

also used to determine whether a site 

visit is appropriate to assess issues 

relating to the health center’s quality of 

care and to determine technical 

assistance needs. 

Likely Respondents: Respondents 

include Health Center Program funds 

recipients seeking deemed PHS 

employee status for purposes of FTCA 

coverage. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Application for Health Center Program ................................

Deemed Public Health Service Employment Status (Initial) 35 1 35 2.5 87.5 

Application for Health Center Program ................................

Deemed Public Health Service Employment Status (Redeeming) ........................................................................... 1,125 1 1,125 2.5 2,812.5 

Total .............................................................................. 1,160 ........................ 1,160 ........................ 2,900 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 23 / Friday, February 5, 2021 / Notices 8365 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–02393 Filed 2–4–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group 

Infectious Diseases, Reproductive Health, 

Asthma and Pulmonary Conditions Study 

Section. 

Date: March 2–3, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting) 

Contact Person: Paul Hewett-Marx, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 

Bethesda, MD 20892 (856) 313–7960 

hewettmarxpn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR20–117: 

Maximizing Investigators’ Research Award 

(MIRA) for Early Stage Investigators (R35— 

Clinical Trial Optional). 

Date: March 4–5, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Emily Foley, Scientific 

Review Officer, Center for Scientific Review, 

6701 Rockledge Drive, Bethesda, MD 20892, 

(301) 402–3016, emily.foley@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Hypersensitivity, Allergies and Mucosal 

Immunology. 

Date: March 4–5, 2021. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Michelle Marie Arnold, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 435–1199, 

michelle.arnold@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 1, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02389 Filed 2–4–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group; Mechanisms of Cancer 

Therapeutics—2 Study Section. 

Date: March 3–5, 2021. 

Time: 1:00 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Careen K.Tang-Toth, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804 Bethesda, MD 20892, (301) 435– 

3504 tothct@csr.nih.gov. 

Name of Committee: Emerging 

Technologies and Training Neurosciences 

Integrated Review Group; Bioengineering of 

Neuroscience, Vision and Low Vision 

Technologies Study Section. 

Date: March 4–5, 2021. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Robert C. Elliott, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5190, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

3009, elliotro@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Behavioral Neuroscience. 

Date: March 4–5, 2021. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 

Rockledge II, 6701 Rockledge Drive Bethesda, 

MD 20892 (Virtual Meeting) 

Contact Person: Mei Qin, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5213 

Bethesda, MD 20892, (301) 875–2215 

qinmei@csr.nih.gov. 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Neurobiology of 

Motivated Behavior Study Section. 

Date: March 4–5, 2021. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Janita N. Turchi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, turchij@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Risks, Prevention and Health 

Behavior. 

Date: March 4–5, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Martha M. Faraday, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808 Bethesda, MD 20892, (301) 435– 

3575, faradaym@csr.nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 


jbell on DSKJLSW7X2PROD with NOTICES